Abeona Therapeutics (ABEO) Non-Current Debt (2018 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Non-Current Debt of $4.8 million for Q1 2026, down 57.32% year-over-year from $11.1 million in Q1 2025, and down 39.15% quarter-over-quarter from $7.8 million in Q4 2025.
Abeona Therapeutics (ABEO) Non-Current Debt (2018 - 2026) Analysis & Trends
Abeona Therapeutics' Non-Current Debt history runs 8 years deep, the most recent figure standing at $4.8 million for Q1 2026.
- In Q1 2026, Non-Current Debt fell 57.32% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $4.8 million (down 57.32% YoY), while the FY2025 annual figure was $7.8 million, down 40.07% from the prior year.
- Non-Current Debt for Q1 2026 stood at $4.8 million, down from $7.8 million in the prior quarter.
- The five-year high for Non-Current Debt was $18.1 million in Q1 2024, with the low at $3.9 million in Q1 2022.
- The 4-year median for Non-Current Debt is $10.9 million (2025), against an average of $9.7 million.
- The sharpest annual moves came in 2022 and 2026: Non-Current Debt surged 224.15% in 2022, then sank 57.32% in 2026.
- Abeona Therapeutics' Non-Current Debt stood at $4.2 million in 2022, then soared by 213.16% to $13.0 million in 2024, then plunged by 40.07% to $7.8 million in 2025, then plunged by 39.15% to $4.8 million in 2026.
- Business Quant data shows ABEO's Non-Current Debt at $4.8 million in Q1 2026, $7.8 million in Q4 2025, and $10.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 882.16 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 8.96 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | 1.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.66 Mn |
| Mar 31, 2026 | 4.75 Mn |
| Dec 31, 2025 | 7.81 Mn |
| Sep 30, 2025 | 10.86 Mn |
| Jun 30, 2025 | 14.01 Mn |
| Mar 31, 2025 | 11.14 Mn |
| Dec 31, 2024 | 13.04 Mn |
| Sep 30, 2024 | 14.21 Mn |
| Jun 30, 2024 | 16.13 Mn |
| Mar 31, 2024 | 18.08 Mn |
| Dec 31, 2022 | 4.16 Mn |
| Sep 30, 2022 | 4.06 Mn |
| Jun 30, 2022 | 4.01 Mn |
| Mar 31, 2022 | 3.92 Mn |
| Dec 31, 2021 | 3.83 Mn |
| Sep 30, 2021 | 8.36 Mn |
| Mar 31, 2021 | 1.21 Mn |
| Dec 31, 2020 | 1.43 Mn |
| Sep 30, 2019 | 20.00 Mn |
| Dec 31, 2018 | 20.00 Mn |